Vir Biotechnology
$13.669876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.68 (+5.24%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours
Why Robinhood?
You can buy or sell VIR and other stocks, options, ETFs, and crypto commission-free!
About VIR
Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. Read More The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.
Employees
—
Headquarters
San Francisco, California
Founded
2016
Market Cap
1.42B
Price-Earnings Ratio
0.00
Dividend Yield
—
Average Volume
136.16K
High Today
$14.10
Low Today
$12.89
Open Price
$12.96
Volume
151.99K
52 Week High
$16.50
52 Week Low
$11.65